- Home
- AFRM vs SNN Comparison
AFRM vs SNN Comparison
Compare AFRM & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFRM
- SNN
- Stock Information
- Founded
- AFRM 2012
- SNN 1856
- Country
- AFRM United States
- SNN United Kingdom
- Employees
- AFRM N/A
- SNN N/A
- Industry
- AFRM Business Services
- SNN Industrial Specialties
- Sector
- AFRM Consumer Discretionary
- SNN Health Care
- Exchange
- AFRM Nasdaq
- SNN Nasdaq
- Market Cap
- AFRM 13.2B
- SNN 12.3B
- IPO Year
- AFRM 2021
- SNN 1999
- Fundamental
- Price
- AFRM $42.10
- SNN $25.93
- Analyst Decision
- AFRM Buy
- SNN Hold
- Analyst Count
- AFRM 22
- SNN 3
- Target Price
- AFRM $66.53
- SNN $27.00
- AVG Volume (30 Days)
- AFRM 8.4M
- SNN 1.2M
- Earning Date
- AFRM 05-08-2025
- SNN 02-25-2025
- Dividend Yield
- AFRM N/A
- SNN 2.89%
- EPS Growth
- AFRM N/A
- SNN 56.15
- EPS
- AFRM N/A
- SNN 0.47
- Revenue
- AFRM $2,800,203,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- AFRM $39.43
- SNN $6.42
- Revenue Next Year
- AFRM $24.67
- SNN $5.03
- P/E Ratio
- AFRM N/A
- SNN $27.69
- Revenue Growth
- AFRM 46.27
- SNN 4.70
- 52 Week Low
- AFRM $22.25
- SNN $23.65
- 52 Week High
- AFRM $82.53
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- AFRM 44.23
- SNN 41.26
- Support Level
- AFRM $39.35
- SNN $25.63
- Resistance Level
- AFRM $42.68
- SNN $26.32
- Average True Range (ATR)
- AFRM 4.16
- SNN 0.74
- MACD
- AFRM 0.62
- SNN -0.13
- Stochastic Oscillator
- AFRM 62.74
- SNN 41.06
About AFRM Affirm Holdings Inc.
Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.